News | July 13, 2011

Siemens Receives 2011 Frost & Sullivan Award for New Product Innovation

Siemens Receives 2011 Frost & Sullivan Award for New Product Innovation

July 13, 2011 – Based on its recent analysis of the medical imaging market, Siemens Healthcare was given the 2011 North American Frost & Sullivan Award for New Product Innovation. Siemens' Biograph mMR is the first scanner capable of simultaneously acquiring whole-body positron emission tomography (PET) and magnetic resonance imaging (MRI) data. "While the ability to fuse and spatially register PET and MRI data has been available for several years, no manufacturer has successfully integrated these two modalities into a single-gantry, whole-body scanner," said Frost & Sullivan research analyst Roberto Aranibar. Simultaneous acquisition of PET and MRI data reduces overall procedure time by providing PET/MRI in a single scan, thus eliminating any time required for patient transport. Faster procedure times improve the patient experience and enables faster delivery of images to clinicians for review. The collection of MRI attenuation data during diagnostic scanning also reduces procedure time and improves clinical workflow. With a footprint comparable to a standard, high-field MRI scanner, the Biograph mMR can be sited in existing MRI rooms, eliminating renovation costs for customers seeking to replace an existing MRI. "The ability to be used in an MR-only capacity, when PET is not clinically indicated, helps keep utilization of the scanner high, and the ability to perform PET/MRI within the time frame of a typical MRI procedure helps maximize patient throughput and maintain good clinical work-flow," said Aranibar. Based on its imaging characteristics and capabilities, PET/MRI is initially expected to find the strongest interest among clinicians and researchers in neurology, oncology, cardiology and pediatric imaging.* Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in the following categories: innovative element of the product, leverage of leading edge technologies, value-added features/benefits, increased customer ROI and customer acquisition/penetration potential. Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research in order to identify best practices in the industry. *MR scanning has not been established as safe for imaging fetuses and infants under two years of age. The responsible physician has to decide about the benefit of the MRI examination in comparison to other imaging procedures. For more information: www.awards.frost.com, www.siemens.com/healthcare

Related Content

A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
Siemens Healthineers Showcases syngo Virtual Cockpit for More Flexible Workforce Management
News | Teleradiology | November 25, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
News | Radiology Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Dual-Agent PET/MR With Time of Flight Detects More Cancer

Tc-99m MDP bone scan (left) is negative for osseous lesions. NaF/FDG PET/MRI (right and second slide) confirms absence of bone metastases, but shows liver metastases. Image courtesy of Stanford University.

News | PET-MRI | June 20, 2017
Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (...